Dermatology · San Francisco, CA
NPI
1760474894
Since 2005
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
450 Sutter St, Ste 1306
San Francisco, CA, 94108
Phone (415) 781-4083
Groups this clinician bills Medicare through
Medicare paid, 2024
$197K
3,394 services
Medicare patients, 2024
811
Average age 76
Drug cost, 2024
$806K
2,305 prescriptions
Company payments, 2025
$3,414
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lucia R Tuffanelli was code 17003 (destruction skin lesion), 860 times for 189 patients. In total Lucia R Tuffanelli billed 3,394 services in 49 codes, and Medicare paid $197K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 860 | 189 | $5.85 | $5,030 |
| 99213 Office E&M - Established | Office | 859 | 516 | $71.54 | $61K |
| 17000 Destruction Skin Lesion | Office | 356 | 228 | $51.12 | $18K |
| 96910 Skin | Office | 201 | 12 | $110.24 | $22K |
| 17110 Destruction Skin Lesion | Office | 201 | 169 | $99.68 | $20K |
| 99212 Office E&M - Established | Office | 160 | 144 | $45.50 | $7,280 |
| 99214 Office E&M - Established | Office | 153 | 112 | $101.83 | $16K |
| 99203 Office E&M - New | Office | 121 | 121 | $85.12 | $10K |
| 11102 Skin Biopsy | Office | 82 | 76 | $87.66 | $7,188 |
| 99202 Office E&M - New | Office | 50 | 50 | $54.92 | $2,746 |
| 11900 Skin | Office | 45 | 29 | $44.52 | $2,003 |
| 99204 Office E&M - New | Office | 31 | 31 | $127.10 | $3,940 |
| 96573 Skin | Office | 20 | 19 | $208.62 | $4,172 |
| J7308 Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 20 | 19 | $293.80 | $5,876 |
| 11103 Skin Biopsy | Office | 16 | 15 | $44.31 | $709 |
By year: 2022 $206K for 3,522 services; 2023 $208K for 3,484 services; 2024 $197K for 3,394 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lucia R Tuffanelli prescribed most often to Medicare patients was Triamcinolone Acetonide, with 252 prescriptions and refills. In total Lucia R Tuffanelli wrote 2,305 Medicare prescriptions that cost $806K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 252 | 275 | 155 | $2,885 |
| Ketoconazole Generic | 246 | 259 | 119 | $4,165 |
| Hydrocortisone Generic | 133 | 136 | 69 | $1,629 |
| Clobetasol Propionate Generic | 127 | 135 | 73 | $5,474 |
| Fluocinonide Generic | 114 | 137 | 67 | $6,858 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 105 | 109 | 67 | $2,141 |
| Ciclopirox Ciclopirox Olamine | 104 | 116 | 49 | $5,248 |
| Azelaic Acid Generic | 99 | 119 | 43 | $11K |
| Minoxidil Generic | 97 | 239 | 31 | $1,579 |
| Doxycycline Hyclate Generic | 63 | 69 | 41 | $709 |
| Clindamycin Phosphate Generic | 59 | 65 | 28 | $2,107 |
| Mupirocin Generic | 55 | 55 | 42 | $343 |
| Prednisone Generic | 54 | 67 | 24 | $237 |
| Gabapentin Generic | 42 | 44 | 12 | $211 |
| Metronidazole Generic | 41 | 45 | 25 | $2,343 |
Brand drugs: 184 claims; generic drugs: 2,121 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lucia R Tuffanelli $3,414 ($3,414 in general payments such as food, travel and fees) from 20 companies. The largest payer was Janssen Biotech, Inc. with $481.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 17 | $481 |
| UCB, Inc. UCB.BR | 18 | $388 |
| Abbvie Inc. ABBV | 19 | $356 |
| Galderma Laboratories, L.P. GALD.SW | 14 | $296 |
| Incyte Corporation INCY | 28 | $282 |
| Genzyme Corporation SNY | 11 | $261 |
| Pfizer Inc. PFE | 10 | $242 |
| Arcutis Biotherapeutics, Inc. ARQT | 13 | $224 |
| LEO Pharma Inc. | 15 | $181 |
| Lilly USA, LLC LLY | 8 | $181 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.